Cargando…

MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling

The rapid onset of resistance to cetuximab (CTX) limits its clinical utility in colorectal cancer (CRC) patients. This study aims to understand a potential role of mismatch repair gene mutL homolog 1 (MLH1) in CTX response. Functional analysis of MLH1 in Her‐2/phosphoinositide 3‐kinases (PI3K)/PKB p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Ying, Peng, Yinghui, Fu, Yaojie, Cai, Changjing, Guo, Cao, Liu, Shanshan, Li, Yiyi, Chen, Yihong, Shen, Edward, Long, Kexin, Wang, Xinwen, Yu, Jian, Shen, Hong, Zeng, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341094/ https://www.ncbi.nlm.nih.gov/pubmed/32670759 http://dx.doi.org/10.1002/advs.202000112

Ejemplares similares

M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer
por: Cai, Changjing, et al.
Publicado: (2021)

Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer
por: Pussila, Marjaana, et al.
Publicado: (2018)

Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice
por: Morioka, Takamitsu, et al.
Publicado: (2015)

Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1
por: Hinrichsen, Inga, et al.
Publicado: (2014)

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner
por: Han, Ying, et al.
Publicado: (2022)

The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
por: Allen, Joshua E., et al.
Publicado: (2013)

Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells
por: Zhang, S., et al.
Publicado: (2017)

Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth
por: Somuncu, Berna, et al.
Publicado: (2022)

Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling
por: Zhou, Ya, et al.
Publicado: (2019)

FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer
por: Chen, Yihong, et al.
Publicado: (2020)

MLH1 deficiency leads to deregulated mitochondrial metabolism
por: Rashid, Sukaina, et al.
Publicado: (2019)

Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
por: Allen, Joshua E., et al.
Publicado: (2013)

BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation
por: Deng, Ganlu, et al.
Publicado: (2018)

MLH1 Deficiency Enhances Tumor Cell Sensitivity to Ganciclovir
por: O’Konek, Jessica J., et al.
Publicado: (2009)

A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers
por: Chen, Yihong, et al.
Publicado: (2023)

An intronic mutation in MLH1 associated with familial colon and breast cancer
por: Bianchi, F., et al.
Publicado: (2010)

HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer
por: Luo, Hai, et al.
Publicado: (2021)

ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells
por: Guo, Cao, et al.
Publicado: (2017)

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model
por: Cai, Changjing, et al.
Publicado: (2022)

Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer
por: Ackermann, Anne, et al.
Publicado: (2019)

Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms
por: Bosch, Dustin E., et al.
Publicado: (2022)

Platycodin D sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the PI3K/Akt signaling pathway
por: Liu, Yanfei, et al.
Publicado: (2022)

The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma
por: Fu, Yaojie, et al.
Publicado: (2018)

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
por: Fu, Yaojie, et al.
Publicado: (2019)

Localization of MLH3 at the Centrosomes
por: Roesner, Lennart M., et al.
Publicado: (2014)

MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer
por: Scarpa, Melania, et al.
Publicado: (2021)

PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
por: Li, Xiaoman, et al.
Publicado: (2016)

MUS81 Generates a Subset of MLH1-MLH3–Independent Crossovers in Mammalian Meiosis
por: Holloway, J. Kim, et al.
Publicado: (2008)

Lynch Syndrome Associated with Two MLH1 Promoter Variants and Allelic Imbalance of MLH1 Expression
por: Hesson, Luke B, et al.
Publicado: (2015)

Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation
por: Pinto, Diana, et al.
Publicado: (2018)

Human MutLγ, the MLH1–MLH3 heterodimer, is an endonuclease that promotes DNA expansion
por: Kadyrova, Lyudmila Y., et al.
Publicado: (2020)

Cetuximab improves AZD6244 antitumor activity in colorectal cancer HT29 cells in vitro and in nude mice by attenuating HER3/Akt pathway activation
por: Zhang, Qin, et al.
Publicado: (2018)

Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
por: Huang, Zhen, et al.
Publicado: (2021)

Reduced MLH3 Expression in the Syndrome of Gan-Shen Yin Deficiency in Patients with Different Diseases
por: Du, Juan, et al.
Publicado: (2017)

Mlh1 deficiency increases the risk of hematopoietic malignancy after simulated space radiation exposure.
por: Patel, Rutulkumar, et al.
Publicado: (2018)

MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas
por: Kaneko, Enami, et al.
Publicado: (2021)

MSH2 and MLH1 testing
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma
por: Feng, Ziyang, et al.
Publicado: (2022)

Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast
por: Vogelsang, Matjaz, et al.
Publicado: (2009)

Inhibition of MEIS3 Generates Cetuximab Resistance through c-Met and Akt
por: Cai, Ping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bq1h6psjbapddu9cgt2mbh9a8e